The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process

被引:36
作者
Grohganz, Holger [1 ]
Lee, Yan-Ying [1 ]
Rantanen, Jukka [1 ]
Yang, Mingshi [1 ]
机构
[1] Univ Copenhagen, Dept Pharm, DK-2100 Copenhagen, Denmark
关键词
Polymorphism; Spray-drying; Freeze-drying; Protein; Mannitol; PROTEIN STABILIZATION; PHYSICAL STATE; DRUG; CRYSTALLIZATION; SPECTROSCOPY; EXCIPIENTS; STABILITY; SORBITOL; BEHAVIOR; PRODUCT;
D O I
10.1016/j.ijpharm.2013.03.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Freeze-drying and spray-drying are often applied drying techniques for biopharmaceutical formulations. The formation of different solid forms upon drying is often dependent on the complex interplay between excipient selection and process parameters. The purpose of this study was to investigate the influence of the chosen drying method on the solid state form. Mannitol-lysozyme solutions of 20 mg/mL, with the amount of lysozyme varying between 2.5% and 50% (w/w) of total solid content, were freeze-dried and spray-dried, respectively. The resulting solid state of mannitol was analysed by near-infrared spectroscopy in combination with multivariate analysis and further, results were verified with X-ray powder diffraction. It was seen that the prevalence of the mannitol polymorphic form shifted from beta-mannitol to delta-mannitol with increasing protein concentration in freeze-dried formulations. In spray-dried formulations an increase in protein concentration resulted in a shift from beta-mannitol to alpha-mannitol. An increase in final drying temperature of the freeze-drying process towards the temperature of the spray-drying process did not lead to significant changes. It can thus be concluded that it is the drying process in itself, rather than the temperature, that leads to the observed solid state changes. (C) 2013 Elsevier B. V. All rights reserved.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 30 条
[1]   Development and physico-mechanical characterisation of lyophilised chitosan wafers as potential protein drug delivery systems via the buccal mucosa [J].
Ayensu, Isaac ;
Mitchell, John C. ;
Boateng, Joshua S. .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2012, 91 :258-265
[2]   INCREASED THERMAL-STABILITY OF PROTEINS IN THE PRESENCE OF SUGARS AND POLYOLS [J].
BACK, JF ;
OAKENFULL, D ;
SMITH, MB .
BIOCHEMISTRY, 1979, 18 (23) :5191-5196
[3]   Freeze-dried whole plasma: Evaluating sucrose, trehalose, sorbitol, mannitol and glycine as stabilizers [J].
Bakaltcheva, Irina ;
O'Sullivan, Anne Marie ;
Hmel, Peter ;
Ogbu, Helen .
THROMBOSIS RESEARCH, 2007, 120 (01) :105-116
[4]   Investigation into the subambient behavior of aqueous mannitol solutions using temperature-controlled Raman microscopy [J].
Beattie, J. Renwick ;
Barrett, Lindsay J. ;
Malone, John F. ;
McGarvey, John J. ;
Nieuwenhuyzen, M. ;
Kett, Vicky L. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 67 (02) :569-578
[5]   In-situ near-infrared spectroscopy monitoring of the lyophilization process [J].
Brülls, M ;
Folestad, S ;
Sparén, A ;
Rasmuson, A .
PHARMACEUTICAL RESEARCH, 2003, 20 (03) :494-499
[6]  
Burger A, 2000, J PHARM SCI-US, V89, P457, DOI 10.1002/(SICI)1520-6017(200004)89:4<457::AID-JPS3>3.0.CO
[7]  
2-G
[8]   Influence of Process Conditions on the Crystallization and Transition of Metastable Mannitol Forms in Protein Formulations During Lyophilization [J].
Cao, Wenjin ;
Xie, Yong ;
Krishnan, Sampathkumar ;
Lin, Hong ;
Ricci, Margaret .
PHARMACEUTICAL RESEARCH, 2013, 30 (01) :131-139
[9]   Effect of mannitol crystallization on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant humanized anti-IgE monoclonal antibody [J].
Costantino, HR ;
Andya, JD ;
Nguyen, PA ;
Dasovich, N ;
Sweeney, TD ;
Shire, SJ ;
Hsu, CC ;
Maa, YF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (11) :1406-1411
[10]   Near infrared and Raman spectroscopy for the in-process monitoring of pharmaceutical production processes [J].
De Beer, T. ;
Burggraeve, A. ;
Fonteyne, M. ;
Saerens, L. ;
Remon, J. P. ;
Vervaet, C. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 417 (1-2) :32-47